Cargando…

Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model

Physical activity is emerging as an alternative nonpharmaceutical strategy to prevent and treat a variety of cardiovascular diseases due to its cardiac and skeletal muscle beneficial effects. Oxidative stress occurs in skeletal muscle of chronic heart failure (CHF) patients with possible impact on m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardi, Eleonora, Majerczak, Joanna, Zoladz, Jerzy A., Tyrankiewicz, Urszula, Skorka, Tomasz, Chlopicki, Stefan, Jablonska, Magdalena, Bar, Anna, Jasinski, Krzysztof, Buso, Alessia, Salvadego, Desy, Nieckarz, Zenon, Grassi, Bruno, Bottinelli, Roberto, Pellegrino, Maria Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606516/
https://www.ncbi.nlm.nih.gov/pubmed/31267722
http://dx.doi.org/10.14814/phy2.14161
_version_ 1783431913348792320
author Bardi, Eleonora
Majerczak, Joanna
Zoladz, Jerzy A.
Tyrankiewicz, Urszula
Skorka, Tomasz
Chlopicki, Stefan
Jablonska, Magdalena
Bar, Anna
Jasinski, Krzysztof
Buso, Alessia
Salvadego, Desy
Nieckarz, Zenon
Grassi, Bruno
Bottinelli, Roberto
Pellegrino, Maria Antonietta
author_facet Bardi, Eleonora
Majerczak, Joanna
Zoladz, Jerzy A.
Tyrankiewicz, Urszula
Skorka, Tomasz
Chlopicki, Stefan
Jablonska, Magdalena
Bar, Anna
Jasinski, Krzysztof
Buso, Alessia
Salvadego, Desy
Nieckarz, Zenon
Grassi, Bruno
Bottinelli, Roberto
Pellegrino, Maria Antonietta
author_sort Bardi, Eleonora
collection PubMed
description Physical activity is emerging as an alternative nonpharmaceutical strategy to prevent and treat a variety of cardiovascular diseases due to its cardiac and skeletal muscle beneficial effects. Oxidative stress occurs in skeletal muscle of chronic heart failure (CHF) patients with possible impact on muscle function decline. We determined the effect of voluntary‐free wheel running (VFWR) in preventing protein damage in Tgαq*44 transgenic mice (Tg) characterized by a delayed CHF progression. In the early (6 months) and transition (12 months) phase of CHF, VFWR increased the daily mean distance covered by Tg mice eliminating the difference between Tg and WT present before exercise at 12 months of age (WT Pre‐EX 3.62 ± 1.66 vs. Tg Pre‐EX 1.51 ± 1.09 km, P < 0.005; WT Post‐EX 5.72 ± 3.42 vs. Tg Post‐EX 4.17 ± 1.8 km, P > 0.005). This effect was concomitant with an improvement of in vivo cardiac performance [(Cardiac Index (mL/min/cm(2)): 6 months, untrained‐Tg 0.167 ± 0.005 vs. trained‐Tg 0.21 ± 0.003, P < 0.005; 12 months, untrained‐Tg 0.1 ± 0.009 vs. trained‐Tg 0.133 ± 0.005, P < 0.005]. Such effects were associated with a skeletal muscle antioxidant response effective in preventing oxidative damage induced by CHF at the transition phase (untrained‐Tg 0.438 ± 0.25 vs. trained‐Tg 0.114 ± 0.010, P < 0.05) and with an increased expression of protein control markers (MuRF‐1, untrained‐Tg 1.12 ± 0.29 vs. trained‐Tg 14.14 ± 3.04, P < 0.0001; Atrogin‐1, untrained‐Tg 0.9 ± 0.38 vs. trained‐Tg 7.79 ± 2.03, P < 0.01; Cathepsin L, untrained‐Tg 0.91 ± 0.27 vs. trained‐Tg 2.14 ± 0.55, P < 0.01). At the end‐stage of CHF (14 months), trained‐Tg mice showed a worsening of physical performance (decrease in daily activity and weekly distance and time of activity) compared to trained age‐matched WT in association with oxidative protein damage of a similar level to that of untrained‐Tg mice (untrained‐Tg 0.62 ± 0.24 vs. trained‐Tg 0.64 ± 0.13, P > 0.05). Prolonged voluntary physical activity performed before the onset of CHF end‐stage, appears to be a useful tool to increase cardiac function and to reduce skeletal muscle oxidative damage counteracting physical activity decline.
format Online
Article
Text
id pubmed-6606516
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66065162019-07-15 Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model Bardi, Eleonora Majerczak, Joanna Zoladz, Jerzy A. Tyrankiewicz, Urszula Skorka, Tomasz Chlopicki, Stefan Jablonska, Magdalena Bar, Anna Jasinski, Krzysztof Buso, Alessia Salvadego, Desy Nieckarz, Zenon Grassi, Bruno Bottinelli, Roberto Pellegrino, Maria Antonietta Physiol Rep Original Research Physical activity is emerging as an alternative nonpharmaceutical strategy to prevent and treat a variety of cardiovascular diseases due to its cardiac and skeletal muscle beneficial effects. Oxidative stress occurs in skeletal muscle of chronic heart failure (CHF) patients with possible impact on muscle function decline. We determined the effect of voluntary‐free wheel running (VFWR) in preventing protein damage in Tgαq*44 transgenic mice (Tg) characterized by a delayed CHF progression. In the early (6 months) and transition (12 months) phase of CHF, VFWR increased the daily mean distance covered by Tg mice eliminating the difference between Tg and WT present before exercise at 12 months of age (WT Pre‐EX 3.62 ± 1.66 vs. Tg Pre‐EX 1.51 ± 1.09 km, P < 0.005; WT Post‐EX 5.72 ± 3.42 vs. Tg Post‐EX 4.17 ± 1.8 km, P > 0.005). This effect was concomitant with an improvement of in vivo cardiac performance [(Cardiac Index (mL/min/cm(2)): 6 months, untrained‐Tg 0.167 ± 0.005 vs. trained‐Tg 0.21 ± 0.003, P < 0.005; 12 months, untrained‐Tg 0.1 ± 0.009 vs. trained‐Tg 0.133 ± 0.005, P < 0.005]. Such effects were associated with a skeletal muscle antioxidant response effective in preventing oxidative damage induced by CHF at the transition phase (untrained‐Tg 0.438 ± 0.25 vs. trained‐Tg 0.114 ± 0.010, P < 0.05) and with an increased expression of protein control markers (MuRF‐1, untrained‐Tg 1.12 ± 0.29 vs. trained‐Tg 14.14 ± 3.04, P < 0.0001; Atrogin‐1, untrained‐Tg 0.9 ± 0.38 vs. trained‐Tg 7.79 ± 2.03, P < 0.01; Cathepsin L, untrained‐Tg 0.91 ± 0.27 vs. trained‐Tg 2.14 ± 0.55, P < 0.01). At the end‐stage of CHF (14 months), trained‐Tg mice showed a worsening of physical performance (decrease in daily activity and weekly distance and time of activity) compared to trained age‐matched WT in association with oxidative protein damage of a similar level to that of untrained‐Tg mice (untrained‐Tg 0.62 ± 0.24 vs. trained‐Tg 0.64 ± 0.13, P > 0.05). Prolonged voluntary physical activity performed before the onset of CHF end‐stage, appears to be a useful tool to increase cardiac function and to reduce skeletal muscle oxidative damage counteracting physical activity decline. John Wiley and Sons Inc. 2019-07-02 /pmc/articles/PMC6606516/ /pubmed/31267722 http://dx.doi.org/10.14814/phy2.14161 Text en © 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Bardi, Eleonora
Majerczak, Joanna
Zoladz, Jerzy A.
Tyrankiewicz, Urszula
Skorka, Tomasz
Chlopicki, Stefan
Jablonska, Magdalena
Bar, Anna
Jasinski, Krzysztof
Buso, Alessia
Salvadego, Desy
Nieckarz, Zenon
Grassi, Bruno
Bottinelli, Roberto
Pellegrino, Maria Antonietta
Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title_full Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title_fullStr Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title_full_unstemmed Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title_short Voluntary physical activity counteracts Chronic Heart Failure progression affecting both cardiac function and skeletal muscle in the transgenic Tgαq*44 mouse model
title_sort voluntary physical activity counteracts chronic heart failure progression affecting both cardiac function and skeletal muscle in the transgenic tgαq*44 mouse model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606516/
https://www.ncbi.nlm.nih.gov/pubmed/31267722
http://dx.doi.org/10.14814/phy2.14161
work_keys_str_mv AT bardieleonora voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT majerczakjoanna voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT zoladzjerzya voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT tyrankiewiczurszula voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT skorkatomasz voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT chlopickistefan voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT jablonskamagdalena voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT baranna voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT jasinskikrzysztof voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT busoalessia voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT salvadegodesy voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT nieckarzzenon voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT grassibruno voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT bottinelliroberto voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel
AT pellegrinomariaantonietta voluntaryphysicalactivitycounteractschronicheartfailureprogressionaffectingbothcardiacfunctionandskeletalmuscleinthetransgenictgaq44mousemodel